Dr. Anna Spreafico, MD PhD
Claim this profilePrincess Margaret Cancer Centre
Studies Cancer
Studies Squamous Cell Carcinoma
12 reported clinical trials
23 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
PD-L1 positive
2Squamous Cell Carcinoma
Stage III
Stage IV
p16 positive
Affiliated Hospitals
Clinical Trials Anna Spreafico, MD PhD is currently running
SGN-PDL1V
for Cancer
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Recruiting1 award Phase 1
Dostarlimab
for Head and Neck Cancer
The goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with HNSCC (Head and Neck Squamous Cell Carcinoma)
Recruiting1 award Phase 3
More about Anna Spreafico, MD PhD
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Anna Spreafico, MD PhD has experience with
- MET-4
- Nivolumab
- Anetumab Ravtansine
- Gemcitabine Hydrochloride
- Ipilimumab
- Anti-androgen
Breakdown of trials Anna Spreafico, MD PhD has run
Cancer
Squamous Cell Carcinoma
Solid Tumors
Parotid Gland Cancer
Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Anna Spreafico, MD PhD specialize in?
Is Anna Spreafico, MD PhD currently recruiting for clinical trials?
Are there any treatments that Anna Spreafico, MD PhD has studied deeply?
What is the best way to schedule an appointment with Anna Spreafico, MD PhD?
What is the office address of Anna Spreafico, MD PhD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.